- Home
- LBTYA vs LNTH Comparison
LBTYA vs LNTH Comparison
Compare LBTYA & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBTYA
- LNTH
- Stock Information
- Founded
- LBTYA 2004
- LNTH 1956
- Country
- LBTYA Bermuda
- LNTH United States
- Employees
- LBTYA N/A
- LNTH N/A
- Industry
- LBTYA Cable & Other Pay Television Services
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- LBTYA Telecommunications
- LNTH Health Care
- Exchange
- LBTYA Nasdaq
- LNTH Nasdaq
- Market Cap
- LBTYA 6.9B
- LNTH 6.8B
- IPO Year
- LBTYA N/A
- LNTH 2015
- Fundamental
- Price
- LBTYA $19.94
- LNTH $101.98
- Analyst Decision
- LBTYA Buy
- LNTH Strong Buy
- Analyst Count
- LBTYA 8
- LNTH 8
- Target Price
- LBTYA $25.50
- LNTH $125.86
- AVG Volume (30 Days)
- LBTYA 1.4M
- LNTH 715.5K
- Earning Date
- LBTYA 10-29-2024
- LNTH 10-31-2024
- Dividend Yield
- LBTYA N/A
- LNTH N/A
- EPS Growth
- LBTYA N/A
- LNTH 1157.80
- EPS
- LBTYA N/A
- LNTH 6.07
- Revenue
- LBTYA $7,593,800,000.00
- LNTH $1,438,011,000.00
- Revenue This Year
- LBTYA $3.77
- LNTH $19.64
- Revenue Next Year
- LBTYA $1.45
- LNTH $8.77
- P/E Ratio
- LBTYA N/A
- LNTH $16.79
- Revenue Growth
- LBTYA 3.96
- LNTH 27.83
- 52 Week Low
- LBTYA $15.01
- LNTH $50.20
- 52 Week High
- LBTYA $20.60
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- LBTYA 61.34
- LNTH 48.04
- Support Level
- LBTYA $19.04
- LNTH $102.11
- Resistance Level
- LBTYA $20.60
- LNTH $109.60
- Average True Range (ATR)
- LBTYA 0.41
- LNTH 4.47
- MACD
- LBTYA 0.10
- LNTH -0.01
- Stochastic Oscillator
- LBTYA 68.72
- LNTH 42.65
About LBTYA Liberty Global Ltd.
Liberty Global is a holding company with interests in several telecom companies in the U.K., Netherlands, Belgium, Switzerland, Ireland, and Slovakia. Liberty is the owner of the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile-network-operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.